MEG3 and breast cancer: Moreover, a regulative mechanism occurring in BC has been described, in which MEG3 was able to downregulate miR-494-3p expression levels, while miR-494-3p was shown to target the DNA methyltransferase 1 (DNMT1) in a cell model of BC.